Testimonial By Sinan Suzen

Sinan-Suzen

Read what our Authors have to say about publishing in our Journal

Journal Name: Current Drug Metabolism

Contributed Article:  Volatile Inhibitors of Phosphatidylinositol-3-Kinase (PI3K) Pathway: Anticancer Potential of Aroma Compounds of Plant Essential Oils

New Issue | Current Neuropharmacology ; Volume 18 Issue 2

 

CN

AIMS & SCOPE

Current Neuropharmacology aims to provide current, comprehensive/mini reviews and guest edited issues of all areas of neuropharmacology and related matters of neuroscience. The reviews cover the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience.

The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.

 

Articles from the journal: Current Neuropharmacology; Volume 18 Issue 2

For details on the articles, please visit this link: http://www.eurekaselect.com/node/603/current-neuropharmacology/issue/18/2718/2/9592

New Issue | Current Nanoscience; Volume 16 Issue 1

cnano-1

 

Current Nanoscience publishes (a) Authoritative/Mini Reviews, and (b) Original Research and Highlights written by experts covering the most recent advances in nanoscience and nanotechnology. All aspects of the field are represented including nano-structures, nano-bubbles, nano-droplets and nanofluids. Applications of nanoscience in physics, material science, chemistry, synthesis, environmental science, electronics, biomedical nanotechnology, biomedical engineering, biotechnology, medicine and pharmaceuticals are also covered. The journal is essential to all researches involved in nanoscience and its applied and fundamental areas of science, chemistry, physics, material science, engineering and medicine.

Current Nanoscience also welcomes submissions on the following topics of Nanoscience and Nanotechnology:

  • Nanoelectronics and photonics
  • Advanced Nanomaterials
  • Nanofabrication and measurement
  • Nanobiotechnology and nanomedicine
  • Nanotechnology for energy
  • Sensors and actuator
  • Computational nanoscience and technology

Articles from the journal: Current Nanoscience; Volume 16 Issue 1

 

 

 

For details on the articles, please visit this link: http://www.eurekaselect.com/node/604/current-nanoscience/issue/16/2729/1/9535

Wishing you a very Happy Birthday | Dr. Jean-Marc Sabatier

 

Dr. Jean-Marc Sabatier

 

Dr. Jean-Marc Sabatier serves as the Editor-in-Chief of the Journals:

Jean-Marc Sabatier
Laboratoire ERT 62 ‘Ingénierie des peptides à visée thérapeutique’
Université de la Méditerranée
Faculté de Médecine Nord
Boulevard Pierre Dramard
13916 – MARSEILLE, Cedex 20
France

Bentham Science Central Nervous System Collection

THE COLLECTION INCLUDE ARTICLES FROM THESE JOURNALS

 

CN_4-4.jpg  CNSAMC.JPG  cnsnddt-flyer.jpg  car

and many more Books…

✔ 130 Journals

✔ 7 Book Series

✔ 45 Books in Total 

 

FEATURES AND BENEFITS: 

♦ Access to over 11,000 scholarly articles covering several aspects of Central Nervous System

♦ Contents come from more than 100 Bentham Science Journals (40 journals indexed in JCR 2017 with impact factor rankings)

♦ Includes both; Original Research and Review Articles

♦ Research from leading institutions in USA, EUROPE, AUSTRALIA, JAPAN, CHINA and other regions

♦ Suitable for researchers in industry and academia wishing to keep updated with latest developments

♦ Easy access to institutions and individuals through IP-based authentication

♦ Access new Neuroscience Research included in this collection as soon as it is published

 

FLEXIBLE PACKAGES 

 Over 950 articles from 2018
 Over 2,764 articles from the last 3 years 
 More than 9,000 articles from the last 10 years

 

Annual addition of over 1,000 new Central Nervous System related articles each year

Tailor-made packages available for pharmaceuticals companies, research institutes, universities, hospitals, clinical/academic societies, and corporations.

 

You can also send your librarian’s contact information to us at marketing@benthamscience.net  CC: hermain@benthamscience.net

 

 

To learn more about our Central Nervous System Collection, please visit  our website: http://bit.ly/2tOEZRo

Press Release | Modified LDL particles activate inflammatory pathways in monocyte-derived macrophages

The article by Dr. . Alexander N. Orekhov et al. is published in Current Pharmaceutical Design, 2018

 

One of the main characteristics of atherosclerosis is the accumulation of lipids in the intimal layer of the arterial wall. In atherosclerotic plaques, phagocytic cells, such as macrophages, engulf atherogenic low-density lipoprotein (LDL) particles, but are unable to process them, and thus become foam cells, having cytoplasm packed with lipid droplets. Foam cells are characterized by several typical features: they have decreased ability to migrate, while displaying enhanced production of pro-inflammatory cytokines. Therefore foam cells participate in maintaining chronic inflammation in the lesion. Such changes of phenotype in comparison to normal macrophages should be based on changes in gene expression patterns of these cells. The study of foam cell formation is of key importance to our understanding of atherosclerosis pathogenesis and for the development of novel diagnostic and therapeutic tools. However, little is known so far on gene expression changes that take place during conversion of macrophages to foam cells.

Previous studies have shown several clusters of genes up- or down-regulated in macrophages in response to oxidized LDL, which is known to be atherogenic. Among the up-regulated genes were scavenger receptors SCA and CD36, nuclear receptors PPARγ, LXRα and RXRγ, and cholesterol efflux protein ABCA1. Regarding the inflammatory response, modified LDL appeared to trigger up-regulation of genes with anti-inflammatory activities, such as IL1-RA, DSCR1, annexin 1, and the Burton’s tyrosine kinase repressor SH3 protein, and down-regulation of a number of pro-inflammatory genes, including leukotriene A4 hydrolase, cathepsin G, elastase 2, RNase A family 2 and 3 proteins, cytochromeb-245, and CD64. However, modern powerful tools, such as transcriptome analysis, may provide more detailed data on change of gene expression patterns during atherosclerotic plaque development and reveal causative relationships between gene expression patterns and pathologic phenotypic alterations.

We performed a transcriptome analysis of macrophages treated with atherogenic LDL that causes intracellular cholesterol accumulation. We used the strategy of upstream analysis for causal interpretation of the expression changes. This strategy has three major steps: (1) analysis of promoters and enhancers of identified differentially expressed genes to identify transcription factors involved in the process under study; (2) reconstruction of signaling pathways that activate these transcription factors; and (3) identification of master-regulators of these pathways.

In this study, we used human monocyte-derived macrophages treated with different lipoprotein-containing samples : high-density lipoprotein (HDL), native LDL, which does not induce cholesterol accumulation in cultured cells, and 3 types of modified atherogenic LDL (oxidized LDL, acetylated LDL and desialylated LDL). In this experiment, low concentrations of native LDL and HDL did not increase the total or esterified cholesterol content in cultured macrophages. After incubation with the substances, mRNA was isolated from the cells and analysed using high-throughput sequencing on HiSeq 1500.

In this study, we discovered 27 transcription factors, including c-Ets, GR-alpha, BRCA1, E2F-1, E2F-6 and EGR-1, that were potentially responsible for the changes in gene expression induced by modified atherogenic LDL. These transcription factors were used for identifying the master-regulators (genes and proteins) responsible for regulation of large cascades of differentially expressed genes. The most reliable of identified master-regulators were IL7R, TIGIT, CXCL8, F2RL1, EIF2AK3, IL7, TSPYL2, ANXA1, DUSP1 and IL15. In the Discussion section of our paper, we give more detail on each of these master-regulators. In general, the genes that were up-regulated in response to lipid accumulation in macrophages induced by atherogenic LDL were mostly involved in inflammation and immune response, and not in cholesterol metabolism. Our results suggest a possibility that it is not cholesterol accumulation that causes an innate immunity response, but rather the immune response is a consequence of a cellular reaction to modified LDL. These results highlight the importance of the inflammatory component in the pathogenesis of atherosclerosis.

Article by Disease | Design and Characterization of Mucoadhesive Gelatin-Ethylcellulose Microparticles for the Delivery of Curcumin to the Bladder

Bentham Oncology Collection | Oncology | Bladder Cancer 

 

Graphical Abstract:

 

Abstract:

Background: Bladder cancer is the second type of malignant carcinoma of the urinary tract. The treatment is time-consuming and requires maintenance doses of the drug for long period of time with important side effects. Curcumin has shown evident clinical advances in the treatment of cancer. The technology of microencapsulation and the use of mucoadhesive materials can contribute to modify the delivery and improve the bioavailability of curcumin.

Objective: The aim of this study was to design and characterize mucoadhesive microparticles containing curcumin using multivariate analysis and the spray-drying technique.

Methods: A factorial design 32+1 was employed to investigate the influence of gelatin, ethylcellulose, and curcumin on size, polydispersity index, drug content and entrapment efficiency. Microparticles were also evaluated by ATR-FTIR, X-ray diffraction, antioxidant activity, in-vitro release profile, exvivo mucoadhesion performance, and in-vitro cytotoxicity.

Results: Microparticles showed non-uniform surface, mean diameter from 2.73 µm to 4.62 µm and polydispersity index from 0.72 to 1.09, according to the different combinations of the independent factors. These independent variables also had a significant effect on the drug content. The highest values of drug trapping efficiency were obtained with the highest concentration of curcumin and polymers. Formulations displayed slow drug release and important antioxidant activity. The good mucoadhesive performance of microparticles was assessed by the falling film technique. Moreover, the formulations did not display in vitro toxicity against Artemia salina and Fibroblasts LM(TK).

Conclusion: The design results were useful for developing of curcumin dosage form with good physicochemical characteristics and mucoadhesive properties for the bladder administration.

 

Find out more at: http://www.eurekaselect.com/node/161813/article

Article by Disease | An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth

Bentham Oncology Collection | Oncology Bladder Cancer 

 

Graphical Abstract:

 

Abstract:

Background: Recent reports of the remarkable therapeutic efficacy of 225Ac-labeled PSMA- 617 for therapy of metastatic castration-resistant prostate cancer have underlined the clinical potential of targeted alpha therapy.

Objective and Conclusion: This review describes methods for the production of 225Ac and its daughter nuclide 213Bi and summarizes the current clinical experience with both alpha emitters with particular focus on recent studies of targeted alpha therapy of bladder cancer, brain tumors, neuroendocrine tumors and prostate cancer.

 

 

Find out more at: http://www.eurekaselect.com/node/161764/article

Article by Disease | Ultrasonography Fused with PET-CT Hybrid Imaging

Bentham Oncology Collection | Oncology | Anal Cancer

Abstract:

We present a method with fusion of images of three modalities 18F-FDG PET, CT, and 3-D ultrasound (US) applied to imaging of the anal canal and the rectum. To obtain comparable geometries in the three imaging modalities, a plexiglas rod, with the same dimensions as the US transducer, is placed in the anal canal prior to the PET-CT examination. The method is based on manual co-registration of PET-CT images and 3-D US images. The three-modality imaging of the rectum-anal canal may become useful as a supplement to conventional imaging in the external radiation therapy in the treatment of anal cancer, where the precise delineation of a tumor is crucial to avoid damage from radiation therapy to the healthy tissue surrounding it. The technique is still in a phase of development, and the demands for integration different company software systems are significant before commercial application. Three-modality imaging may also be used in certain other diagnostic or therapeutic fields.

 

 

Browse the article details at: http://www.eurekaselect.com/node/74230/article

New Issue :: Micro and Nanosystems (Volume: 10, Issue: 1)

 

Micro and Nano-systems publishes significant original work, topical reviews and guest edited issues ranging from technologies and systems to product innovation and new manufacturing processes with features at the micro and nanoscale. Applications for micro and nano-systems in areas such as health, environment, food, security and consumer goods are covered. The topics to be addressed include lab-on-a-chip, microfluidics, nano-biotechnology, micro and nano manufacturing, printed electronics and MEMS.

 

mns

 

Articles from the journal Micro and Nanosystems Volume 10, Issue 1:

 

For details on the articles, please visit this link ::  https://bit.ly/2OTrpC5

 

 

 

%d bloggers like this: